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a b s t r a c t
Background: Radiation induced brain injury ranges from acute reversible edema to late,
irreversible radiation necrosis. Radiation induced temporal lobe necrosis is associated with
permanent neurological deﬁcits and occasionally progresses to death.
Objective: We present our experience with surgery on radiation induced temporal lobe
necrosis (RTLN) in nasopharyngeal carcinoma (NPC) patients with special consideration
of clinical presentation, surgical technique, and outcomes.
Method: This retrospective study includes 12 patients with RTLN treated by the senior author
between January 2010 and December 2014. Patients initially sought medical treatment due to
headache; other symptoms were hearing loss, visual deterioration, seizure, hemiparesis,
vertigo, memory loss and agnosia. A temporal approach through a linear incision was
performed for all cases. RTLN was found in one side in 7 patients, and bilaterally in 5. 4
patients underwent resection of necrotic tissue bilaterally and 8 patients on one side.
Results: No death occurred in this series of cases. There were no post-operative complica-
tions, except 1 patient who developed aseptic meningitis. All 12 patients were free from
headache. No seizure occurred in patients with preoperative epilepsy. Other symptoms such
as hemiparesis and vertigo improved in all patients. Memory loss, agnosia and hearing loss
did not change post-operatively in all cases. The follow-up MR images demonstrated no
recurrence of necrotic lesions in all 12 patients.
Conclusion: Neurosurgical intervention through a temporal approach with linear incision is
warranted in patients with radiation induced temporal lobe necrosis with signiﬁcant
symptoms and signs of increased intracranial pressure, minimum space occupying effect
on imaging, or neurological deterioration despite conservative management.
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Nasopharyngeal carcinoma (NPC) is the most malignant
nasopharyngeal tumor. It occurs more frequently in Southern
China, speciﬁcally in the Canton province. The incidence of
NPC in Canton province is 25 times higher than that in the rest
of the world, thus NPC is often called Canton cancer. NPC is
also found in some parts of Southeast Asia, the Mediterranean
basin, and Alaska [1]. According to a study by Cao et al., the
incidence NPC is as high as 27.2 per 100,000 person-years in
men in China [2]. Radiation therapy is the most effective
treatment. With a radiation dose between 66 and 70 Gray(Gy), 5
years survival rate may reach 80% [3]. The most frequent
complication of the radiation is brain necrosis, with an
incidence of approximately 2–4% [4]. This complication does
inﬂuence patient quality of life. Many regions of the supra or
infratentorial can be affected by radiation, such as the
temporal lobes, frontal lobes, brain stem, and cerebellum.
Patients who harbor temporal lobes necrosis are particularly at
risk for transtentorial herniation given the limited space of the
middle cranial fossa.
According to the time symptoms emerge, radiation induced
temporal lobe necrosis (RTLN) can be divided to three stages
[5]: 1 – acute phase: symptoms appear within one month of
radiation therapy, 2 – subacute phase: symptoms appear in 1–6
months, 3 – chronic phase: symptoms appear more than 6
months after radiation therapy.
There two types of therapeutic treatment for RTLN in NPC
patients. The ﬁrst method is conservative, which is indicated
for most patients or in medically unstable patients. Conserva-
tive treatment includes: steroids, osmotic diuretics such as
mannitol and furosemide, hyperbaric oxygen therapy, Bev-
acizumab (Avastin) and anticoagulation (heparin, warfarin,
antiplatelets), etc. If conservative management does not
change the symptoms or they become more severe, suggesting
brain herniation, surgery is the most effective tool. In spite of
the simplicity of the RTLN operation, careful patient selection
is very important. Because the majority of these patients are
old or systemically ill, timing of surgery and the extension of
the resection while preserving the functional areas of the
temporal lobe are mandatory too.
In this study we present our experience with surgery of
RTLN in NPC patients with non-life threatening edema or
occupying mass effect with special consideration of clinical
presentation, surgical techniques, and outcomes.
2. Materials and methods
2.1. Patient population
We retrospectively reviewed the data of 12 NPC patients with
RTLN treated by the senior author (L.F.C.) in our neurosurgical
center between January 2010 and December 2014. We excluded
radiation induced brain necrosis due to other skull and brain
pathology, e.g. AVM, glioma, meningioma, etc. The diagnosis
of RTLN in NPC patients was established based on tumor
histopathology, which was initially performed by transnasal
endoscopy in the Ear, Nose and Throat (ENT) department priorto radiation therapy. Our cohort included 12 patients; all are
males, aged 42–64 years (mean, 53.5 years). The initial radiation
dose ranged between 66 and 75 Gy, (mean, 70 Gy). There were no
repeated radiation therapy cases due to NPC recurrence.
Radiotherapy was performed using two-dimensional radiother-
apy (2DRT) or intensity-modulated radiotherapy (IMRT) in our
institute or others. With an interval time between last course of
radiation therapy and initial symptoms of 2–17 years (mean, 7.6
years). The initial symptom for which they sought medical help
was headache, sometimes accompanied by vomiting; other
symptoms were hearing loss, visual deterioration, seizure,
hemiparesis, vertigo, short and long memory loss and agnosia.
The most important demographic and clinical features of the
patients included in this study are outlined in Table 1.
2.2. Neuro-imaging studies
Radiographic evaluation included brain Magnetic Resonance
Imaging (MRI) scans as well as Computed Tomography (CT).
The nature of the RTLN, its extensions and relationship to
neighboring structures were studied using MR images, as MRI
appears to have higher sensitivity than CT in diagnosing RTLN.
CT scans, with the aid of bone algorithm, were obtained for
analysis of bone involvement. Magnetic resonance spectros-
copy (MRS) and Diffusion Weighted MRI (DWI) are best suited
to differentiate between RTLN and recurrence of NPC, post
radiation second primary intracranial malignancies, hema-
togenous cerebral metastasis and brain abscess.
2.3. Surgical technique
The patient is placed in a supine position and the ipsilateral
shoulder is raised with a cushion to facilitate head rotation.
The head is ﬁxed in a three-pin Mayﬁeld head holder with a
single pin placed in the frontal area to allow free manipulation
during the procedure.
After precise orientation, the borders of the craniotomy
and incision are marked with a sterile pen. We use a straight
line incision 1 cm in front of the tragus to avoid injury to
the neurovascular structure of the pre-auricular region.
The inferior border of this incision starts at the level of the
zygomtic arch and the upper border ends 2–3 cm above
the pinna with a small anterior curve to facilitate retraction of
the edges of the skin incision with the temporalis muscle for
wide exposure later.
A craniotome is used to create a 34 mm (width)  55 mm
(height) bone ﬂap. In intradural stage, for cystic lesions, we
began by tapping and aspirating the ﬂuid inside the cyst with
a ventricular cannula. We then resected the inferior tempo-
ral lobe along the inferior temporal sulcus to the Sylvain
ﬁssure. Our resection of the normal temporal lobe tissue did
not exceed 4 cm in the dominant side and 5 cm in the non-
dominant side, to prevent any post-operative complications.
We removed some, not all, of the cystic wall and tried to
ensure communication the cyst with neighboring ventricles
or arachnoid cisterns (ambient cistern) to prevent reforma-
tion of the cyst and reaccumulation of the ﬂuid causing
relapse of the cyst. For solid tumors, we resected the inferior
temporal lobe as in cystic lesions, and tried to remove all
necrotic tissue and enhanced lesion found on MRI to prevent











1 M 57 17 66 Headache, seizure Bilateral temporal lobe, right frontal lobe necrotic cysts.
2 M 63 2 68 Headache, vomiting,
hearing loss
Left side temporal lobe irregular enhancement, midline
shift to the right.
3 M 52 4 75 Headache, hearing loss Left side temporal lobe necrotic cysts with edema.
4 M 64 12 68 Headache, hemiparesis Bilateral temporal lobes necrotic cysts, edema, midline
shift.
5 M 59 2 72 Headache, memory
loss, seizure
Left side temporal lobe irregular enhancement with
severe edema.
6 M 48 13 70 Headache, hearing loss,
vertigo
Bilateral temporal lobes necrotic cysts.
7 M 52 11 75 Headache, vomiting Left side temporal lobe irregular enhancement with
edema.
8 M 48 7 68 Headache, hemiparesis Right side temporal lobe necrotic cysts with edema.
9 M 53 9 75 Headache, agnosia,
hearing loss
Right side temporal lobe necrotic cyst.
10 M 42 3 75 Headache, memory loss Bilateral temporal lobes, irregular enhancement nodules.
11 M 55 6 70 Headache Left temporal lobe necrotic cyst.
12 M 50 6 66 Headache, blurred vision,
memory loss, weakness
in lower limbs
Bilateral temporal lobes necrotic cysts, midline shift
compressing midbrain.
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ic tissue from the Sylvain ﬁssure, we were careful not to
injure the middle cerebral artery (MCA). Some residual
necrotic tissue was left to adhere to vessels to prevent
postoperative infarction. Similarly to cystic lesion, we aimed
to communicate cisterns with each other, by opening the
crural and ambient cisterns and the Sylvian ﬁssure. For
patients with preoperative epilepsy, intraoperative electro-
corticography may be used to guide resection of electrically
abnormal areas.
3. Results
With the exception of case 1, who was intubated by
tracheostomy due to severe trismus and skull base osteor-
adionecrosis, all patients were orally intubated. Our imaging
studies showed unilateral RTLN in 7 patients and bilateral in
5 patients. For patients harboring bilateral temporal lobe
necrosis with mass effect (cases 1, 6 and 12), one stage
operation was done for both sides. For all other cases,
we operated on the side with mass effect, with close
postoperative follow up. There was no operative mortality.
There were no postoperative complications, except in case 12,
who developed aseptic meningitis, which was treated by
steroids and continuous lumbar drainage for 3–5 days.
Postoperative follow up ranged from 5 to 47 months (mean,
20.6 months). All patients survived without operation-related
morbidity. All 12 patients were free from headache, and no
seizures occurred in the patients with preoperative epilepsy.
Other symptoms such as hemiparesis and vertigo improved
in all patients. Agnosia, memory and hearing loss did not
change following surgery. The follow-up MR images demon-
strated no recurrence of necrotic lesions in all 12 patients. For
surgical descriptions and outcomes, see Table 2.3.1. Illustrative case report (Patient No. 11, Fig. 1)
A 55-year-old man underwent radiotherapy for nasopharyn-
geal carcinoma (NPC) in 2007. He presented in January 2013
with headache. On magnetic resonance imaging (MRI), a
5.6 cm  4.1 cm cystic lesion was found in the left temporal
lobe with minimal compression of the left ventricle and the
basal ganglia, within the area previously irradiated. He
proceeded with left side temporal cystic lesion resection
through a temporal approach. The patient was placed in a
supine position. After deﬁnition of the craniotomy, the skin
was prepped and draped in standard fashion. A vertical
straight epifascial skin incision was made at the level of the
zygomatic arch. After elevation of the temporalis muscle, a
34 mm (width)  55 mm (height) bone ﬂap was created. After
opening the dura in cruciate fashion, the necrotic cyst wall was
partially removed and communicated with lateral ventricle
and crural and ambient cisterns. Postoperative histology
revealed coagulative and ﬁbrinoid necrosis, ischemic neurons,
hyalinized blood vessel walls, telangiectasia, chronic inﬂam-
matory cells and reactive gliosis, suggesting radiation induced
temporal lobe necrosis. The postoperative course was un-
eventful and the patient recovered quickly; follow up MRI did
not show any recurrence (Fig. 1).
4. Discussion
Regaud and Schmincke ﬁrst described NPC as a separate
entity in 1921 [6,7]. NPC is arising from the epithelial cells that
cover the surface and line the nasopharynx. NPC is a frequent
head and neck cancer in southern China and Southeast Asia,
such a geographical distribution suggests that NPC has a
strong environmental factor possibly linked to nutrition, such
as nitrosamine contaminated ﬁshes [8]. In addition to
Table 2 – Surgical description, outcome and follow up in 12 RTLN patients.








1 Bilateral Tracheostomy Improve 80 10
2 Left Oral Improve 90 24
3 Left Oral Improve 80 22
4 Right Oral Improve 80 13
5 Left Oral Improve 90 47
6 Bilateral Oral Improve 80 12
7 Left Oral Improve 80 36
8 Right Oral Improve 90 25
9 Right Oral Improve 80 16
10 Bilateral (2 stages) Oral Improve 80 23
11 Left Oral Improve 90 12
12 Bilateral Oral Improve 80 5
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been associated with the etiology of NPC; this is supported by
the ﬁnding that EBV is detected in all undifferentiated NPC
cells [9]. However, some researchers hold the theory that a
speciﬁc inheritable genetic factor inﬂuence on the develop-
ment of the disease [10]. The prognosis of NPC in early stage is
favorable, with 10 year survival of more than 40% [11]. NPC has
extensive skull base invasion or cavernous sinus involvement
in 70% of grade 3 to 4 patients [12]. Because of the proximity to
the nasopharyngeal cavity, the medial and inferior temporalFig. 1 – Preoperative axial T1 (a), T2 (b), T1 with contrast (c) imag
temporal lobe. Intraoperative views show the linear incision an
bone (d), after opening the dura and aspirating the cystic fluid. T
involves the creation of an opening between the cystic lesion an
communicated with basal cisterns (e). Postoperative CT(f). The p
and eosin staining, original magnification T 100) revealed coagu
blood vessel walls, telangiectasia, chronic inflammatory cells an
lobe necrosis(g).lobes are inevitably delineated in the target volume of
irradiation, which increases the risk of temporal lobe
necrosis, a late stage complication after radiotherapy in
NPC. RTLN responds poorly to treatment, and is associated
with permanent neurological deﬁcits and occasionally pro-
gresses to death.
The treatment of NPC is based on radiotherapy and
chemotherapy. Radiotherapy alone has been the ﬁrst curative
treatment of NPC. Many radiotherapy techniques have been
applied in treating NPC patients, such as 2-dimensional (2D)es demonstrating a 5.6 cm T 4.1 cm cystic lesion in the left
d the elevated temporalis muscle exposing the squamous
he cystic wall was partially resected and fenestration
d lateral ventricle (white arrow), and the cyst was
ostoperative histopathological examination (hematoxylin
lative and fibrinoid necrosis, ischemic neurons, hyalinized
d reactive gliosis, suggesting radiation induced temporal
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 1 7 2 – 1 7 9176and 3-dimensional (3D) radiotherapy. 3D radiotherapy tech-
niques such as 3D conformal radiotherapy (3D-CRT) and
intensity-modulated radiation therapy (IMRT) is a new
technique developed in the last 2 decades that achieves good
results in terms of overall survival, locoregional control, as
well as the late toxicity proﬁle comparing to 2D radiotherapy
which has suboptimal target coverage and excessive dose to
normal structures [13].
Tumor control for NPC has been highly correlated with
higher doses of radiation delivered to the tumor. A deﬁnitive
radiation dose between 66 Gy and 70 Gy needs to be given to
the gross tumor volume (GTV), and 54–60 Gy to the clinical
target volume (CTV). Patients with NPC experienced irradia-
tion-induced late complications including radiation-induced
temporal lobe necrosis (RTLN). Factors associated with an
increased risk of RTLN are young age [14], re-irradiation,
total radiation dose [15], fraction schedule, administrationRTLN
Asymptomatic Mild  to 
Moderate






Fig. 3 – Flow diagrams for tre
Fig. 2 – The three most common features of RTLN on MRI, finge
bubble on T2(c).of chemoradiotherapy and type of radiotherapy technique
[16].
The mechanisms of RTLN are not completely understood.
The most accepted theories suggest that radiation necrosis is a
continuous process from endothelial cell dysfunction to tissue
hypoxia and necrosis, with the concomitant release of
inﬂammatory factors, such as tumor necrosis factor-a (TNF-
a), interleukin-1b (IL-1b) [17], and vasoactive compounds, such
as the vascular endothelial growth factor (VEGF), which can
lead to progressive blood–brain barrier dysfunction and brain
edema [18,19].
Pathologically, in its early stage, RTLN is characterized by
demyelination of oligodendrocytes associated with axonal
edema due to damage of the blood–brain barrier [20,21], while
in late stages; it is characterized by coagulation, ﬁbrinoid
necrosis and dissolving or disappearing of nerve cells in the
irradiation ﬁeld, with reactive glial cell proliferation. Finally,Sever e
Decompressive S urgery +  Necr oti c
tissu e resecti on
Not controlled
Necr otic tissu e 
 (linear incision)
atment of RTLN patients.
r-like edema on T2 (a), flower lace on T1 + C (b), and soap
1- In spite of con serv ative management, there is 
progress ive neurologic al dysfunction
2- Long-te rm depend ence on corticosteroid 
therapy
3- Severe edema  with mass effect on CT/MRI
4- Establishment of histop athologic diagnosis
Fig. 4 – Indications for surgical intervention in RTLN
patients in our center.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 1 7 2 – 1 7 9 177the whole process results in a cystic lesion, as seen in Fig. 6,
case 12. The progressive impairment of the endothelium
induced by radiation may lead to the thickening of the
microvascular wall, which ultimately leads to changes in
cerebral white matter demyelination [22,23].
In a study by Greene-Schloesser et al. [24] clinical
presentations of RTLN were divided into acute and late stages,
with acute stage being characterized by headache, nausea,
vomiting due to high intracerebral pressure, seizure, fever, and
even acute changes in spiritual consciousness. Almost of these
symptoms are reversible through conservative treatment. In
the late stage, the symptoms are more profound and
irreversible, including cognitive impairments like memory
loss, hearing loss, aphasia and blurred vision, even blindness.
Some patients will develop temporal lobe transtentorial
herniation due to severe edema around the necrotic lesions,
which represents a medical emergency and requires surgical
intervention.
MRI is more sensitive than CT in diagnosing RTLN. The
features of RTNL on MRI are irregular ﬁnger-like areas
representative of reactive white matter edema, or ‘‘soap
bubble’’ which represents multiple cystic lesions on T2, and
‘‘Flower lace’’ which can be seen on contrast images, such as
that in Fig. 2 [25–27].Fig. 5 – Case 11. The patient presented with headache and mem
edema. The right side edema was more severe than the left side
lesion resection. 5 months later, the patient began to have a hea
(c, d), he underwent resection of the left temporal lobe necrotic The differential diagnosis of RTLN includes recurrence and
extension of NPC cranially, hematogenous metastasis and
primary tumors such as glioma [24]. A diagnostic dilemma
sometimes arises when trying to differentiate RTLN from
intracranial extension of recurrent NPC. Recurrent NPC is
entirely located in the extradural space and is rarely associated
with cerebral edema, whereas RTLN is found in intraaxial
lesions and cerebral edema is common early sign [24]. Magnetic
resonance spectroscopy (MRS) is a noninvasive means of
quantifying various metabolites and studying their distribution
in different tissues, and is helpful in differentiating between
RTLN and primary tumors. In case of RTLN, N-acetyl aspartate
(NAA), creatine (Cr), choline (Cho) are remarkly decreased,
while with primary tumors, Cho is elevated and NAA levels are
diminished or lost entirely [28,29].
The treatment of temporal lobe necrosis depends on
clinical assessment, as depicted in Fig. 3. Observation may
be the only treatment needed in asymptomatic patients.
Conservative treatment, including corticosteroids, osmotic
diuretics such as mannitol and furosemide, hyperbaric oxygen
therapy, Bevacizumab (Avastin, anti-vascular endothelial
growth factor (VEGF)), anti-inﬂammatory agents, and antic-
oagulation (heparin, warfarin, antiplatelets), should be applied
for patients with mild to moderated edema with minimum
brain space-occupying effect. Neurosurgical RTLN resection
can be indicated in cases that failed to respond to conservative
management, involve progressive neurological dysfunction or
long-term dependence on corticosteroid therapy (which
carries the risk of immunosuppression and extensive infec-
tions), show the MRI or CT shows severe edema with mass
effect on MRI or CT, or require establishment of a histopatho-
logic diagnosis due to nonspeciﬁc imaging manifestations of
the temporal mass in irradiated patients with NPC (Fig. 4).
Neurosurgical resection of RTLN is performed through a
temporal approach. Preoperative evaluation of the airway in
RTLN patients has signiﬁcant value in determining the type of
intubation that will be used. Nasotracheal intubation assisted
by ﬂexible ﬁber-optic bronchoscopy is the preferred option forory loss. MRI showed bilateral temporal lobe necrosis with
 (a, b). Patient underwent right side temporal lobe necrotic
dache. MRI showed severe edema on the left temporal side
tissue.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 1 7 2 – 1 7 9178patients with trismus, and tracheostomy is preferred for
patients with damaged or necrotic skull base damaged due the
radiation. Most of our cases were intubated orally; only case 1
was an exception. In most of our cases, the temporal lobe
necrosis was resected through a liner incision. If RTLN
involved both temporal lobes, the side with signiﬁcant mass
effect was operated on ﬁrst (Fig. 5, case 10). When both sides
have the same degree of mass effect, both sides were operated
on in one stage operation, as in case no 12 (Fig. 6). We resected
all the necrotic tissues and enhanced lesions on MRI, as well as
some part of the cyst wall, and tried to communicate cystic
lesions with all neighboring cisterns or the lateral ventricle to
prevent postoperative reformation of the cystic lesion. For
solid lesions, we also tried to open the cisterns and the SylvainFig. 6 – The process of solid necrosis tissue changing to cystic le
diagnosis of bilateral RTLN (a,b), 4 months later (c,d), one year la
bilateral resection of temporal lobe necrotic tissues in one staged
Postoperative histopathologic examination (hematoxylin and eos
proliferation and ectasis and extensive necrosis (i). Postoperativﬁssure following the removal of necrotic lesions. Resection of
the normal temporal tissue cannot exceed 4 cm in the
dominant side and 5 cm in the non-dominant side. For
patients with preoperative epilepsy, intraoperative electro-
corticography may be used to guide resection of electrically
abnormal areas.
In conclusion neurosurgical intervention through a tempo-
ral approach with a linear incision becomes warranted in
patients with RTLN with signiﬁcant symptoms and signs of
increased intracranial pressure, minimum space occupying
effect on imaging, or neurological deterioration despite
conservative management. RTLN patients are systemically
ill, and preoperative patient selection is critical to have
obtaining successful outcomes.sion in a 50 year old patient (Case 12). Images at the time of
ter (e,f), and 16 months later (g,h). The patient underwent
 operation through a linear incision as described for Case 11.
in staining, original magnification T 100) revealed vascular
e CT (j).
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